Objectives: Impaired cerebral autoregulation following neurologic injury is a predictor of poor clinical outcome. We aimed to assess the relationship between body temperature and cerebral autoregulation in comatose patients. Design: Retrospective analysis of prospectively collected data. Setting: Neurocritical care unit of the Johns Hopkins Hospital. Patients: Eighty-five acutely comatose patients (Glasgow Coma Scale score of ≤ 8) admitted between 2013 and 2017. Interventions: None. Measurement and Main Results: Cerebral autoregulation was monitored using multimodal monitoring with near-infrared spectroscopy-derived cerebral oximetry index. Cerebral oximetry index was calculated as a Pearson correlation coefficient between low-frequency changes in regional cerebral oxygenation saturation and mean arterial pressure. Patients were initially analyzed together, then stratified by temperature pattern over the monitoring period: no change (< 1°C difference between highest and lowest temperatures; n = 11), increasing (≥ 1°C; n = 9), decreasing (≥ 1°C; n = 9), and fluctuating (≥ 1°C difference but no sustained direction of change; n = 56). Mixed random effects models with random intercept and multivariable logistic regression analysis were used to assess the association between hourly temperature and cerebral oximetry index, as well as between temperature and clinical outcomes. Cerebral oximetry index showed a positive linear relationship with temperature (β = 0.04 ± 0.10; p = 0.29). In patients where a continual increase or decrease in temperature was seen during the monitoring period, every 1°C change in temperature resulted in a cerebral oximetry index change in the same direction by 0.04 ± 0.01 (p < 0.001) and 0.02 ± 0.01 (p = 0.12), respectively, after adjusting for Paco 2 , hemoglobin, mean arterial pressure, vasopressor and sedation use, and temperature probe location. There was no significant difference in mortality or poor outcome (modified Rankin Scale score of 4-6) between temperature pattern groups at discharge, 3, or 6 months. Conclusions: In acute coma patients, increasing body temperature is associated with worsening cerebral autoregulation as measured by cerebral oximetry index. More studies are needed to clarify the impact of increasing temperature on cerebral autoregulation in patients with acute brain injury. (Crit Care Med 2018; 46:e733-e741) Key Words: autoregulation; coma; hypothermia; neurocritical care; temperature C erebral blood flow (CBF) is closely maintained by myogenic, neurogenic, endothelial, and metabolic mechanisms, which act in response to changes in cerebral perfusion pressure (1, 2). Cerebral autoregulatory dysfunction has been reported in the setting of acute neurologic injury such as traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), intracranial hemorrhage (ICH), and acute ischemic stroke (AIS), as well as postcardiac arrest and in sepsis (3) (4) (5) (6) (7) (8) changes, rendering the brain vulnerable to secondary insults such as ischemia, infarction, or hemorrhages (1). Impaired cerebral autoregulation has indeed been established as a strong predictor of clinical outcome across these conditions (9-12). Identifying factors which contribute to worsening autoregulation may therefore aid in the optimization of clinical recovery in such patients.
C erebral blood flow (CBF) is closely maintained by myogenic, neurogenic, endothelial, and metabolic mechanisms, which act in response to changes in cerebral perfusion pressure (1, 2) . Cerebral autoregulatory dysfunction has been reported in the setting of acute neurologic injury such as traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), intracranial hemorrhage (ICH), and acute ischemic stroke (AIS), as well as postcardiac arrest and in sepsis (3) (4) (5) (6) (7) (8) . In these instances, CBF becomes passive to systemic pressure changes, rendering the brain vulnerable to secondary insults such as ischemia, infarction, or hemorrhages (1) . Impaired cerebral autoregulation has indeed been established as a strong predictor of clinical outcome across these conditions (9) (10) (11) (12) . Identifying factors which contribute to worsening autoregulation may therefore aid in the optimization of clinical recovery in such patients.
Hypothermia has been suggested to offer some form of autoregulatory protection in patients with acute brain injury (13, 14) . Several studies have demonstrated preservation of vascular reactivity to various stimuli during hypothermia following TBI and cardiac arrest (13, 15) . Among these, Lee et al (14) reported a marked decrease in the lower limits of autoregulation with hypothermia in piglets following cardiac arrest compared with those who remained normothermic. Further, Lavinio et al (16) have previously reported impairment of autoregulation, as measured by pressure reactivity index, when brain temperature exceeds 37°C following moderate hypothermia, and Cremer et al (17) noted impaired static autoregulation at temperatures above 40°C. Despite these studies, the effect of body temperature on autoregulatory status in the initial few days following coma onset remains unclear.
This study aimed to assess the relationship between patterns of body temperature and CBF autoregulation. We used the near-infrared spectroscopy (NIRS)-derived cerebral oximetry index (COx) that has been validated in animals and humans as a noninvasive method for the continuous, clinical monitoring of CBF autoregulation (18) (19) (20) . Monitoring CBF autoregulation using NIRS relies on the use of regional cerebral oxygen saturation (rSo 2 ) as a surrogate marker of CBF. Cerebral oxygenation is positively associated with CBF and tissue oxygen diffusivity and negatively related to cerebral metabolic rate; the assumption that these remain stable throughout monitoring underpins the determination of CBF autoregulation using NIRS (21) . The comparison of NIRS-derived rSo 2 with functional MRI-derived CBF by Alderliesten et al (22) demonstrated good correlation (Spearman 0.85; p = 0.00001). We hypothesized that CBF autoregulation, as measured by COx, would be impaired at higher temperatures and improve at lower body temperatures.
METHODS
This is a retrospective analysis of data from an ongoing prospective study evaluating multimodal monitoring using NIRS in neurocritically ill patients. Data collection was approved by the Johns Hopkins School of Medicine Institutional Review Board. This study was subject to waiver of written consent due to minimal risk. Patients were identified from the period 2013-2017 and were eligible if acutely comatose (Glasgow Coma Score [GCS] score of ≤ 8) due to any etiology and being monitored with an arterial catheter. Exclusion criteria included noncomatose patients with a GCS score of less than or equal to 8, unavailability of autoregulation monitoring equipment, and change in temperature probe location during monitoring period. Etiologies included were ICH, SAH, AIS, intraventricular hemorrhage, status epilepticus, meningitis, ventriculitis, encephalopathy, TBI, subdural hemorrhage, and postcardiac arrest.
Autoregulation Monitoring
Patients were monitored at the bedside after admission to the neurocritical care unit (NCCU) of the Johns Hopkins Hospital. All patients had an acute neurologic injury leading to coma; multimodal monitoring was initiated in the first 12-48 hours after coma onset for each patient and was continued for up to 3 days. Monitoring was stopped if the patient emerged from coma or died during this period and was halted or stopped if the patient was sent for a medical procedure. Continuous measurements of rSo 2 of the left and right frontal lobe were made using NIRS INVOS 5100 (cerebral/somatic oximetry monitor; Covidien, Boulder, CO), as previously described (18, 19) . Mean arterial pressure (MAP) was continuously measured from an arterial catheter in the radial or femoral artery placed for clinical indications and connected to the analog outlet of the clinical hemodynamic monitor (Solar 8000i; General Electric, Boston, MA). The arterial transducer was zeroed and leveled at the right atrium after placement and as required per nursing protocol. Both rSo 2 and MAP signals were processed (MAP signals were sampled with an analog-to-digital converter at 60 Hz) using ICM+ software (University of Cambridge, Cambridge, United Kingdom) to generate COx (20) . COx represents a continuous, moving Pearson correlation coefficient between rSo 2 and MAP, where rSo 2 serves as a surrogate for CBF (20) . The moving average of this coefficient was calculated over 10-second intervals in a 5-minute window. Separate left and right COx values were generated; these were then averaged to provide the mean COx for each patient. Autoregulation improves as COx values approach zero and is impaired as values exceed 0.1 (23) .
Temperature Measurements
Temperature measurements were recorded between one-and four-hourly, as determined by the NCCU managing team. Location of temperature measurement varied between patients as directed by the managing team, and included esophageal, rectal, oral, axillary, forehead, and bladder probes. The method of monitoring in an individual patient remained constant during the period of autoregulation monitoring.
Temperature Pattern Group
Patients were grouped by temperature pattern seen over the monitoring period as follows: no change (n = 11), increasing (n = 9), decreasing (n = 9), or fluctuating (n = 56). To determine the overall temperature change throughout the monitoring period, we first identified the minimum (T min ) and maximum (T max ) temperatures achieved in each patient. Patients were categorized as having no temperature change when T max -T min was less than 1°C. Where T max -T min was greater than or equal to 1°C, we plotted absolute temperature against time during monitoring period to assess the trajectory of temperature change. Patients were categorized as having increasing or decreasing temperature when T max -T min was uniformly increased or decreased by greater than or equal to 1°C, respectively. Patients
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Patient Outcome
Neurologic outcome was assessed using the modified Rankin Scale (mRS); assessments were made at hospital discharge, and 3 and 6 months after discharge. These assessments were made from hospital charts and phone calls to patients using the validated telephonic mRS questionnaire (24) .
Data Analysis
Statistical analysis of data was performed using Stata 14 (StataCorp, College Station, TX). The Shapiro-Wilk test was used to assess normality of the continuous baseline variables; none of the variables were normally distributed. Baseline characteristics for each group were therefore compared using linear regression for continuous variables and logistic regression for categorical variables. The relationship between COx and temperature was initially assessed across all patients, before stratifying them into different temperature pattern groups. For each temperature pattern group, scatter plots were used to assess the relationship between COx and temperature prior to statistical analysis. Mixed random effects models with random intercept were then used to assess the association between hourly temperature and COx, adjusting for CO 2 (Paco 2 ), hemoglobin, MAP, vasopressor and sedation use, and temperature probe location, as vasomotor tone is influenced by the former three. To assess the association between temperature and outcomes, we performed multivariable logistic regression. The model was adjusted for age, GCS at coma onset, mRS at admission, maximum intracranial pressure (ICP), midline shift at pineal, and presence of thalamic lesion, herniation, or infection. Significance level was accepted for p values less than 0.05.
RESULTS
A total of 85 patients were eligible and included in this study. All 85 patients were monitored using COx and had temperature recordings during the monitoring period. Patient demographics, comorbidities, and clinical characteristics are given in Table 1 and Supplemental Table 1 (Supplemental Digital Content 1, http://links.lww.com/CCM/D533). The only difference between the temperature groups was Marshall Score. Although probe location varied between patients, there was consistency for each patient during monitoring. There was no difference in the number of patients on each sedative type; however, sedative combinations and any alterations to this were not standardized.
Effect of Temperature on Autoregulation
The temperature changes for each group throughout the monitoring period are shown in Figure 1 . The temperature change for the duration of monitoring (mean ± sd) and p value for this change was 0.32°C ± 0.38°C (p = 0.57) for the no change group, 2.52°C ± 1.07°C (p < 0.001) for the increasing group, 1.77°C ± 1.14°C (p < 0.001) for the decreasing group, and 2.30°C ± 1.41°C (p = 0.39) for the fluctuating temperature group. The duration (mean ± sd) of COx monitoring was 21.2 ± 26.6 hours for the no temperature change group, 50 ± 21.8 hours for the increasing temperature group, 31.3 ± 19.4 hours for the decreasing temperature group, and 46.7 ± 23.7 hours for the fluctuating temperature group (p = 0.002 between groups).
A linear relationship between autoregulation and body temperature was observed for all groups (Fig. 2) . COx increases (worsens) with increasing temperature and decreases (improves) as temperature decreases. Autoregulatory impairment was seen above 38.6°C (Fig. 2C) , and improvement below 36°C (Fig. 2B ) and 36.6°C (Fig. 2D) .
Mixed random effects analysis of the relationship between COx and temperature change are listed in Table 2 . Where all patients were analyzed together, a positive linear relationship was seen; for each 1°C change in temperature, COx changed in the same direction by 0.04 ± 0.10 (p = 0.29). This relationship was significant in the univariate analysis of the no change (p = 0.04) and increasing temperature groups (p < 0.001). Multivariable mixed random effects analysis also showed a significant relationship in these two groups (p = 0.006 for the no change group; p < 0.001 for the increasing temperature group) after adjusting for Paco 2 , hemoglobin, MAP, vasopressor and sedation use, and temperature probe location, indicating that increasing body temperature is independently associated with worsening of autoregulation in acute coma patients in the neurocritical care setting, and that even relatively small variations in temperature may influence autoregulation. 2 Changes in rSo 2 with temperature are demonstrated in Figure 3 . In all groups, apart from the decreasing temperature group, a positive relationship is seen between rSo 2 and temperature; rSo 2 increases with increasing temperature. In the decreasing temperature group, however, rSo 2 is seen to decrease with increasing temperature. The beta coefficients ± sd and p values are 1.6 ± 0.2 (p < 0.001) across all patients, 6.0 ± 1.8 (p = 0.001) for the no change group, 1.6 ± 0.5 (p < 0.001) for the increasing group, -1.1 ± 0.4 (p = 0.02) for the decreasing group, and 1.8 ± 0.3 (p < 0.001) for the fluctuating group.
Effect of Temperature on rSo

Effect of Temperature Pattern on Mortality and Clinical Outcomes
Although our hypothesis and study design do not focus on clinical outcomes, we investigated the relationship of temperature effects and autoregulation on mortality and clinical outcomes. Ninety-nine percent, 82%, and 80% of patient outcome data were available at discharge, 3, and 6 months, respectively. Neither poor outcome, as defined by mRS score of 4-6, nor mortality at discharge, 3, and 6 months were significantly different between each of the groups. The adjusted odds ratio (95% CI) for mortality at each interval assessed are as follows: 11.5 (0.18-744; p = 0.25), 9.6 (0.20-464; p = 0.25), and 29.6 (0.57-1,536; p = 0.09) for the increasing, decreasing, and fluctuating groups, respectively. Multivariable logistic regression analysis was adjusted for age, GCS at coma onset, mRS at admission, maximum ICP, midline shift at pineal, and presence of thalamic lesion, herniation, or infection. 
DISCUSSION
The main finding of this study is that CBF autoregulation, as measured by continuous COx monitoring, was impaired with elevated temperatures. Decreasing temperatures, however, showed some trend toward improvement in CBF autoregulation. Impairment in autoregulation appeared to occur at a temperature greater than 38.6°C and improvement below 36.0-36.6°C.
Fever is common in neurocritically ill patients and is independently associated with poor outcomes following acute brain injury (25) (26) (27) (28) . Our data thus highlight the potential role of impaired CBF autoregulation in contributing to these poor outcomes. Consequently, optimizing cerebral perfusion based on CBF autoregulation monitoring in febrile critically ill patients might provide a means for improving outcomes.
Although a significant relationship between temperature and COx was also seen in the no change group, this may have been due to the large temperature range seen across all patients within this group (33-38°C) (Fig. 2B ). Stratifying these patients further into groups based on mean temperature throughout the monitoring period, that is, normothermia (36-37.5°C; n = 6), hypothermia (32-36°C
; n = 3), and hyperthermia (> 37.5°C; n = 2), would allow us to assess this. However, these subgroups are too small to run regression analysis. The Marshall Scores of patients in the no change and increasing temperature groups were significantly higher than those in the decreasing and fluctuating temperature groups. It has previously been established that autoregulatory disturbances occur more commonly, and to a greater degree, following severe TBI compared with moderate TBI (29-31). Thus, it is possible that autoregulatory responsiveness to temperature is a function of severity of impairment, hence severity of brain injury. Alternatively, as temperature fluctuations are associated with more severe injury, change in temperature may represent an epiphenomenon rather than the cause of the autoregulatory changes seen here. Further prospective studies would be required to confirm these hypotheses.
COx measurements are generated using rSo 2 , with the assumption that cerebral metabolic rate remains constant throughout the period of monitoring. Cerebral metabolic rate, however, is temperature dependent; for each degree centigrade rise in core body temperature, cerebral oxygen requirements increase by up to 13% (32) . Thus, the increase in COx with increasing temperatures seen here may simply be due to metabolism and/ or CBF-associated changes in rSo 2 ; the former may contribute to the effect on autoregulation itself. As these rSo 2 measurements were obtained through forehead sensors, values of COx obtained reflect local CBF autoregulatory changes occurring in the frontal lobe compared with invasive ICP monitoring which provide a global measure (33) . Forehead skin blood flow and external carotid artery conductance also contribute to interference in these measurements (34) . Changes in body temperature influence the magnitude of this contamination; however, since the extent of this influence on rSo 2 measurements is unclear, we were unable to correct for this (35) . Comparisons of rSo 2 changes with temperature demonstrated a similar relationship to that seen between COx and temperature, except in the decreasing group, where the reverse was seen, and the fluctuating group, where a positive relationship was seen. Therefore, it is unlikely that changes in COx seen here are driven by changes in rSo 2 alone. Although we did not see a statistically significant improvement in autoregulation with drop in temperature, this may be because neuroprotective temperatures (< 36°C) (35) were not sustained; the median temperature (interquartile range) in the decreasing temperature group was 36.6°C (1.8) . Previous animal studies have demonstrated significant improvement of autoregulation and vascular reactivity to acetylcholine and hypocapnia where hypothermic temperatures (32-33°C) were reached (13) (14) (15) . It would thus be beneficial to conduct prospective studies assessing autoregulatory changes in patients with temperatures at or lower than 36°C (36) .
Additionally, the effects of neurologic injury on autoregulatory status demonstrate temporal progression across different etiologies of brain injury (37) (38) (39) . It is possible that secondary deterioration of autoregulation occurred in some patients during the monitoring period, which prevented us from seeing statistical significance between temperature decrease and autoregulation as measured by COx. The significant variation in length of monitoring may also have contributed to this, as the monitoring period may not have been long enough to capture any such autoregulatory changes. Indications for cooling in this group of patients included refractory intracranial hypertension and refractory status epilepticus. The decreasing temperature group had the highest mean maximum ICP (31 mm Hg). Furthermore, this group of patients had a higher rate of infection (33%) and pressor requirement (78%); septic shock could have both contributed to hypothermia and worsening of autoregulatory status. Therefore, improvements in autoregulatory status with decreasing temperature may not have been seen due to this group being comprised of more seriously ill patients.
Although there was no statistical difference in the number of patients on each type of sedation between each group, some patients were on multiple sedatives or had a change in sedative during the monitoring period. Sedatives are associated with reductions in both cerebral metabolic rate and CBF, the extent of which is dependent on sedative type and dose (40) . The effects on cerebral metabolic rate would also have influenced rSo 2 measurements. Any changes in dosing or sedative type during the monitoring period may therefore have contributed to the autoregulatory changes seen. Use of vasopressors also increases CBF (41) ; changes in COx may therefore have coincided with vasopressor administration rather than occurring as a result of temperature changes. Despite observing a linear relationship between autoregulation and temperature, this did not translate into differential outcomes between the groups. Although both fever and impaired autoregulation have been independently associated with longterm outcomes, we did not expect to see a relationship between temperature pattern and outcome as this study was not powered to assess this hypothesis. Even though this study investigated a large cohort of acutely comatose patients, there were only a small number of patients in the no change (n = 11), increasing (n = 9), and decreasing (n = 9) groups; the majority of patients were in the fluctuating group (n = 56). The multiple fluctuations in this latter group prevented us from finding a linear relationship. Furthermore, the short observation period could not have been reflective of the patient's overall status throughout the duration of their admission; temperatures outside of this monitoring period are unknown. For example, patients who were febrile by the end of the monitoring period may have had this corrected subsequently, thus restoring autoregulatory function and eliminating the adverse effect of high temperatures. Outcomes may also be associated with length of time at high or low temperatures.
Although our COx data were collected prospectively, the retrospective collection of temperature data in this study and heterogeneity of coma etiology preclude our ability to definitively identify a causal relationship between autoregulatory impairment and changes in temperature. The relationship between temperature and COx may vary between etiologies. The small number of patients within each etiology group in this study, however, prevented us from investigating this in more detail. Although cooling or warming devices were used in a similar proportion of patients within each group (Table 1) , temperature management protocols were not standardized so may also have influenced the results. We also note the difference in location of temperature probes used between patients; bladder probes show a variation of 0.03°C ± 0.23°C from pulmonary artery catheter measurement, compared with axillary probes, which show a greater variability of -0.68°C ± 0.57°C (42) . However, consistency for each patient was sufficient to allow us to assess the association between temperature and changes in CBF autoregulation. We also used rSo 2 measurements as a surrogate of CBF; this can be confounded by changes in acid-base status and Paco 2 (43) . Additionally, this study was limited to comatose patients; assessment of such changes in patients prior and subsequent to coma would be useful.
Although our data present evidence of some temperaturemediated effects on autoregulation, future work would require prospective studies to investigate the relationship between temperature and autoregulation in more detail. Such studies should be conducted across a population of patients with a specific brain injury and include a larger sample size and monitoring of other metabolic indicators. Assessments of the temperature range within which autoregulation is optimal, and whether these changes are dynamic in response to temperature manipulation, should also be made.
CONCLUSIONS
In acute coma patients, increasing body temperature is associated with worsening cerebral autoregulation as measured by COx. Close regulation of temperature within the neurocritical care setting may therefore have a role in management; however, further prospective studies are needed to clarify the impact of changing temperature on cerebral autoregulation in relation to outcomes in patients with acute brain injury. Assessment of temperature effects on neurologic outcomes, in particular, is required to determine whether temperature interventions are warranted.
